M

Manitex Capital Inc
XTSX:MNX

Watchlist Manager
Manitex Capital Inc
XTSX:MNX
Watchlist
Price: 0.075 CAD Market Closed
Market Cap: CA$9.5m

Manitex Capital Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Manitex Capital Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
M
Manitex Capital Inc
XTSX:MNX
Cash & Cash Equivalents
CA$800
CAGR 3-Years
-86%
CAGR 5-Years
-67%
CAGR 10-Years
-55%
HLS Therapeutics Inc
TSX:HLS
Cash & Cash Equivalents
$11.7m
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
G
Greenrise Global Brands Inc
CNSX:XCX
Cash & Cash Equivalents
€1.3k
CAGR 3-Years
-24%
CAGR 5-Years
-59%
CAGR 10-Years
-37%
No Stocks Found

Manitex Capital Inc
Glance View

Market Cap
9.5m CAD
Industry
Health Care

Manitex Capital, Inc. engages in the provision of investment services. The company is headquartered in Kirkland, Quebec. The firm also holds a portfolio of marketable securities in the same fields. The firm through its wholly owned subsidiary, MedbrAin Inc., holds marketable securities.

MNX Intrinsic Value
0.058 CAD
Overvaluation 22%
Intrinsic Value
Price CA$0.075
M

See Also

What is Manitex Capital Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
800 CAD

Based on the financial report for Jul 31, 2024, Manitex Capital Inc's Cash & Cash Equivalents amounts to 800 CAD.

What is Manitex Capital Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-55%

Over the last year, the Cash & Cash Equivalents growth was -95%. The average annual Cash & Cash Equivalents growth rates for Manitex Capital Inc have been -86% over the past three years , -67% over the past five years , and -55% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett